SARS-CoV-2

November 29, 2022

Results from a new molecular study provide a framework to guide engineering of future SARS-CoV-2 vaccines.

November 9, 2021

Molecular research uncovers how these SARS-CoV-2 variants can erode vaccine immunity.

August 30, 2021

Emergency medical responders' training and use of personal protective equipment is credited for low rate of on-the-job infection.

June 11, 2021

Although children may have milder symptoms, they had similar levels of virus as symptomatic adults, researchers found.

March 17, 2021

Antibodies from recovered patients recognize a lesser-known site on the pandemic coronavirus and block infection in lab studies

 

November 16, 2020

The study highlights the value of establishing patients' viral loads and antibody levels upon hospital admission, the researchers say.

October 30, 2020

Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models.

September 24, 2020

Powerful antibody cocktail lock infection machinery, inhibits SARS-CoV-2 attachment to cells, and protects exposed animals.

September 10, 2020

SARS-CoV-2 usually triggers a strong immune response, but less so in men and people over 60.

September 9, 2020

Computer-designed, synthetic miniproteins act as potent, stable antivirals that block coronavirus infection of cultured human cells.

Subscribe to SARS-CoV-2